drug

TYRUKO

updated 3mo ago

by Sandoz Inc

community read0 votes

🐶 often sniffed alongside

top 4

all catalysts(0)

nothing on the calendar yet

Trials studying TYRUKO

phase2Natalizumab for the Treatment of People With Inflammatory Demyelination Suggestive of Multiple Sclerosis, or Definite Multiple Sclerosis, at First Presentation (AttackMS)recruitingn=40

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 47m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

TYRUKO

updated 3mo ago

by Sandoz Inc

community read0 votes

🐶 often sniffed alongside

top 4

all catalysts(0)

nothing on the calendar yet

Trials studying TYRUKO

phase2Natalizumab for the Treatment of People With Inflammatory Demyelination Suggestive of Multiple Sclerosis, or Definite Multiple Sclerosis, at First Presentation (AttackMS)recruitingn=40

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 47m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

TYRUKO

🐶 often sniffed alongside

all catalysts(0)

Trials studying TYRUKO

News(0)

Report a data issue

comments(0)

TYRUKO

🐶 often sniffed alongside

all catalysts(0)

Trials studying TYRUKO

News(0)

Report a data issue

comments(0)